#TLM25
November 10, 2025 at 11:48 AM
Real-world data in clinical practice
-identify CSPH with VTCE & Plt
-VTCE15-20+plt <110
-VTCE 20-20+ plt < 150
-VTCE >20 + any plt
-NSBB for cACLD with CSPH
- Telepression+Albumin - 1st line for HRS-AKI
-Resp Failure Risks- ACLF3 & Hypoxia
#TLM25 @aasldnews.bsky.social
November 9, 2025 at 12:01 AM
November 10, 2025 at 4:29 AM
Great talk on Japan’s success in HCC control #ILCM Satellite meeting #TLM25
November 16, 2024 at 10:51 PM
@intmedatiowa.bsky.social Iowa Liver team is rocking it in DC! 💪

#TLM25 @aasldnews.bsky.social
November 9, 2025 at 1:43 PM
VA hepatitis C team winning the distinguished advocacy award.
Truly well deserved 👏🏼
#liversky
#TLM25
November 8, 2025 at 1:47 AM
Come join us today 12:30 pm outside 209 in center area for a #TLM25 advocacy photo!

#PatientVoice @aasldnews.bsky.social @worldhepalliance.bsky.social @lancetgastrohep.bsky.social
November 8, 2025 at 4:29 PM
Recompensation take home points

⏳off all diuretics and medications for HE
📌happens in 1 out of 3 patients depending etiology
🖋️multiple factors affect it
🔎 improves survival and LR mortality
📍Risk of HCC remains the same: don’t stop screening

@anahitarabiee.bsky.social
#liversky
#TLM25
November 8, 2025 at 1:50 PM
Best practices of management of obesity in liver transplant

FANTASTIC work by @drjessicadavis.bsky.social et al leading a controversy conference and consensus paper 👇🏼👇🏼👇🏼

Her beautiful graph won the cover photo 👌🏼

#liversky
#TLM25
@aasldnews.bsky.social
@ast-licop.bsky.social
November 9, 2025 at 4:09 PM
November 11, 2025 at 12:19 AM
Kicking off the meeting with some of my favorite people
#TLM25 #liversky
November 7, 2025 at 11:57 PM
Next gen hepatology

Session by communication and technology committee

All brilliant speakers!

Proud to have served as the chair of this committee
@aasldnews.bsky.social
#TLM25
#liversky
@howardtleemd.bsky.social
November 10, 2025 at 4:04 PM
So excited to be in Washington DC for my first #TLM25 with wonderful colleagues!

A toast to you all with a delicious mocktail! Will see you around! Can’t wait!

#LiverTwitter @aasldnews.bsky.social
November 8, 2025 at 11:11 AM
How to approach #MASLD at different stages of our patients lives

Fantastic summary slide from @marurinella

#PostGraduateCourse #TLM25 @aasldnews.bsky.social
November 8, 2025 at 11:09 AM
My step count always spikes during academic meetings 🙃‼️
Day 4 👟👟 #TLM25
@childrensnational.bsky.social @aasldnews.bsky.social #WashingtonDC #GrowthStudy
November 11, 2025 at 12:30 AM
Celebrating excellence in hepatology! 🌟
We proudly recognized this year’s awardees and honorees at the #TLM25 Awards & Honors Gala. Join us in congratulating this incredible group of 2025 AASLD Distinguished Awardees! 👏👏
November 8, 2025 at 3:00 PM
#TLM25: Laura Kulik, MD, transplant hepatologist at @nuintmed.bsky.social, in Chicago, speaking on systemic therapy for #HCC at @aasldnews.bsky.social 2025 in Washington, D.C.

Image & quote taken by Senior Correspondent, Larry Luxner.

#RareDisease #Hepatology #HepatocellularCarcinoma #MedSky
November 9, 2025 at 4:37 PM
And if you look after adult patients with #MASLD, here is a cue on how to approach treatment 👇

#TLM25 #LiverSky
November 8, 2025 at 11:09 AM
I'll be covering #TLM25 for @statnews.com this weekend. Say hi if you see me, or lmk what you're most looking forward to learning about!
November 7, 2025 at 4:06 PM
Please join us for our research oral presentation at Ballroom A, level 3 on Sunday, Nov 9, 2025, at 5 pm.
#TLM25 @aasldnews.bsky.social
November 7, 2025 at 12:27 PM
Tobevibart plus elebsiran and tobevibart alone both lowered HDV RNA and ALT levels. The combination resulted in a high incidence of undetectable HDV RNA and an HBsAg level below 10 IU/ml at week 48. Full SOLSTICE phase 2 trial results: nej.md/4qIXpuM

@aasldnews.bsky.social | #TLM25
November 9, 2025 at 11:05 PM
November 10, 2025 at 12:39 AM
November 9, 2025 at 1:57 AM
🎉 #TLM25 Recap

From Nov 7–11, leaders in #Hepatology met in D.C. for @aasldnews.bsky.social's annual The Liver Meeting, sharing key research, patient insights, and innovations in care.

Catch Rare Disease Advisor’s top highlights ➡️ https://bit.ly/4axf17f

#RareDisease #LiverDisease #MedSky
AASLD’s The Liver Meeting 2025: Highlights from #TLM25
Discover key insights, research updates, and highlights from AASLD’s The Liver Meeting 2025 (#TLM25) in Washington, D.C.
bit.ly
December 4, 2025 at 4:10 PM